There are 807 resources available
Panel discussion / Q&A
Presenter: Alvin Wong
Session: Astellas Pharma - The future of advanced urothelial carcinoma treatment is here: A focus on enfortumab vedotin
Resources:
Webcast
Chair's summary: Identifying the right patient for enfortumab vedotin
Presenter: Alvin Wong
Session: Astellas Pharma - The future of advanced urothelial carcinoma treatment is here: A focus on enfortumab vedotin
Resources:
Webcast
CAR T cells in B-Cell malignancies: The way to cure?
Presenter: Won Seog Kim
Session: Developing immunotherapies in haematolgical malignancies
Resources:
Slides
Webcast
Surgical perspectives
Presenter: Christian Simon
Session: Potential benefits and limitations of IO in localised head and neck cancer
Resources:
Slides
Should we be manipulating the microbiome in routine practice?
Presenter: Gal Markel
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Latest advances in diagnosis and molecular biology of GIST (incl. rare subtypes) and their clinical implication
Presenter: Jean-Yves Blay
Session: Latest advances in the treatment of gastrointestinal stromal tumour (GIST)
Resources:
Slides
Webcast
181MO - Secondary cytoreduction in platinum-sensitive relapsed ovarian cancer: An individual patient level meta-analysis
Presenter: Seema Gulia
Session: Mini Oral session: Gynaecological tumours
Resources:
Abstract
Slides
Webcast
43O - Preoperative chemotherapy prior to primary tumor resection for colorectal cancer patients with asymptomatic resectable primary lesion and synchronous unresectable liver-limited metastases (RECUT): A prospective, randomized, controlled, multicenter clinical trial
Presenter: Qi Lin
Session: Proffered Paper and Mini Oral session: Gastrointestinal tumours
Resources:
Abstract
Slides
Webcast
Targeting B-cell lymphomas with bispecific antibodies
Presenter: Mats Jerkeman
Session: Developing immunotherapies in haematolgical malignancies
Resources:
Slides
Webcast
Radiation oncologist perspectives
Presenter: Melvin Lee Kiang Chua
Session: Potential benefits and limitations of IO in localised head and neck cancer
Resources:
Slides
Webcast